Ever Fortune.AI Co., Ltd. (TPEX:6841)
Taiwan · Delayed Price · Currency is TWD 52.50
+0.20 (0.38%)
Aug 19, 2026, 1:30 PM CST
Ever Fortune.AI Revenue
Ever Fortune.AI had revenue of 97.69M TWD in the quarter ending June 30, 2026, with 7.07% growth. This brings the company's revenue in the last twelve months to 382.65M, up 7.81% year-over-year. In the year 2025, Ever Fortune.AI had annual revenue of 378.81M with 12.23% growth.
Revenue (ttm)
382.65M
Revenue Growth
+7.81%
P/S Ratio
13.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 378.81M | 41.29M | 12.23% |
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| Cenra | 8.54B |
| CHC Healthcare Group | 4.65B |
| St.Shine Optical | 3.73B |
| Panion & Bf Biotech | 2.11B |
| Medigen Biotechnology | 1.34B |
| Mycenax Biotech | 815.87M |
| Caliway Biopharmaceuticals | 29.39M |